Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

Market Cap	768.01M -9.5%
Revenue (ttm)	155.60M +34.4%
Net Income	39.29M +99.8%
EPS	0.12 +105.4%
Shares Out	n/a
PE Ratio	19.55
Forward PE	16.00
Dividend	0.03 (1.25%)
Ex-Dividend Date	May 27, 2026

Volume	n/a
Open	2.320
Previous Close	2.220
Day's Range	2.320 - 2.340
52-Week Range	1.880 - 2.980
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About FRA:818

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company’s peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cove...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2012
• Employees: 925
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 818

Financial Performance

In 2025, FRA:818's revenue was 1.06 billion, an increase of 35.15% compared to the previous year's 782.48 million. Earnings were 244.37 million, an increase of 143.75%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error